Abstract
Schizophrenia is a chronic manic-depressive illness. It is a mental illness characterized by a combination of symptoms such as perceptual misinterpretation, cognitive impairment, and emotional dysfunction. Schizophrenia is a serious mental illness that affects various parts of the brain. “A majority of individuals with schizophrenia have poor insight regarding the fact that they have a psychotic illness, “ says the DSM (Diagnostic and Statistical Manual of Mental Disorders). There are a myriad of symptoms associated with schizophrenia illness, arising from different basis. Hence, it adds slight complexity to its further diagnosis. Symptoms must last 6 months and include at least 1 month of active symptoms for an accurate diagnosis. For a precise diagnosis, several clinical symptoms, including physical, psychiatric, and psychological indicators, must be evaluated. Clinical examination includes a variety of tests to diagnose, including blood tests and medical imaging. Combinatorial methods can be used to make accurate diagnoses. Considering the neurochemical changes in mental disorders, identification of biomarkers in psychiatry is becoming increasingly important in order to facilitate diagnosis. The International Classification of Diseases, eleventh revision, has also adopted standardized criteria (ICD-11) for specific Schizophrenia diagnosis. Various diagnostic tests, such as MRIs, CT scans, and blood tests, are usually performed to assess the patient’s health. With the aid of diagnostic tool, several causative factors in schizophrenia pathophysiology have been identified. It is providing a more promising future for easy and safe diagnosis of schizophrenic patient. To achieve even greater improvements in patient care, psychiatrists and researchers synchronized work contributes to improving and developing modified medicine tools.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Ackerman JJH, Grove HT, Wong GG, Gadian DG, Radda GR (1980) Mapping of metabolite in whole animal by 31P NMR using surface coil. Nature 283:167–170. https://pubmed.ncbi.nlm.nih.gov/7350541/. https://doi.org/10.1038/283167a0
Ahokas AR, Rimón M, Koskiniemi A, Vaheri I, Julkunen S, Sarna. (1987) Viral antibodies and interferon in acute psychiatric disorders. J Clin Psychiatry 48:194–196
Aine C, Bockholt HJ, Bustillo JR, Canive JM, Caprihan A, Gasparovic C, Hanlon FM, Houck JM, Jung RE, Lauriello J, Liu J, Mayer AR, Perrone-Bizzozero NI, Posse S, Stephen JM, Turner JA, Clark VP, Calhoun VD (2017) Multimodal neuroimaging in schizophrenia: description and dissemination. Neuroinformatics 15(4):343–364. https://doi.org/10.1007/s12021-017-9338-9
An Der Heiden W, Könnecke R, Maurer K, Ropeter D, Häfner H (2005) Depression in the long-term course of schizophrenia. Eur Arch Psychiatry Clin Neurosci 255(3):174–184. https://doi.org/10.1007/s00406-005-0585-7
Ashok AH, Baugh J, Yeragani VK (2012) Paul eugen bleuler and the origin of the term schizophrenia (SCHIZOPRENIEGRUPPE). Indian J Psychiatry 54:95–96. https://doi.org/10.4103/0019-5545.94660
Bagge EN, Esbjörnsson E, Sunnerhagen KS (2017) Cognitive screening and behavioral observation of functional ability in patients with multiple episode schizophrenia: an exploratory study. BMJ 7(6):1–10. https://doi.org/10.1136/bmjopen-2016-014783
Bansal V, Chatterjee I (2021) Role of neurotransmitters in schizophrenia: a comprehensive study. Kuwait J Sci 48(2). https://doi.org/10.48129/kjs.v48i2.9264
Barch DM (2006) What can research on schizophrenia tell us about the cognitive neuroscience of working memory? Neuroscience 139(1):73–84. https://doi.org/10.1016/j.neuroscience.2005.09.013
Beck-Sander A, Birchwood M, Chadwick P (1997) Acting on command hallucinations: a cognitive approach. Br J Clin Psychol 36(1):139–148. https://doi.org/10.1111/j.2044-8260.1997.tb01237.x
Benros ME, Pedersen MG, Rasmussen H, Eaton WW, Nordentoft M, Mortensen PB (2014) A nationwide study on the risk of autoimmune diseases in individuals with a personal or a family history of schizophrenia and related psychosis. Am J Psychiatry 171:218–226. https://doi.org/10.1176/appi.ajp.2013.13010086
Bentall RP, Corcoran R, Howard R, Blackwood N, Kinderman P (2001) Persecutory delusions: a review and theoretical integration. Clin Psychol Rev 21(8):1143–1192. https://doi.org/10.1016/S0272-7358(01)00106-4
Bigler ED (1987) The clinical significance of cerebral atrophy in dementia. Arch Clin Neuropsychol 2:177–190
Birchwood M, Mason R, MacMillan F, Healy J (1993) Depression, demoralization and control over psychotic illness: a comparison of depressed and non-depressed patients with a chronic psychosis. Psychol Med 23(2):387–395. https://doi.org/10.1017/S0033291700028488
Birtwistle J, Baldwin D (1998) Role of dopamine in schizophrenia and Parkinson’s disease. Br J Nurs 7(14):832–841. https://doi.org/10.12968/bjon.1998.7.14.5636
Bligh EG, Dyer WJ (1959) A rapid method of total lipid extraction and purification. Can J Biochem 1959(37):911–917. https://doi.org/10.1139/o59-09
Bolton C, Gooding P, Kapur N, Barrowclough C, Tarrier N (2007) Developing psychological perspectives of suicidal behaviour and risk in people with a diagnosis of schizophrenia: we know they kill themselves but do we understand why? Clin Psychol Rev 27(4):511–536. https://doi.org/10.1016/j.cpr.2006.12.001
Brown AS, Derkits EJ (2010) Prenatal infection and schizophrenia: a review of epidemiologic and translational studies. Am J Psychiatry 167(2010):261–280. https://doi.org/10.1176/appi.ajp.2009.09030361
Brown S, Kim M, Mitchell C, Inskip H (2010) Twenty-five year mortality of a community cohort with schizophrenia. Br J Psychiatry 196:116–121. https://doi.org/10.1192/bjp.bp.109.067512
Burt DR, Creese I, Snyder SH (1977) Antischizophrenic drugs: chronic treatment elevates dopamine receptor binding in brain. Science 196(4287):326–328. https://doi.org/10.1126/science.847477
Caldwell CB, Gottesman II (1992) Schizophrenia—a high-risk factor for suicide: clues to risk reduction. Suicide Life Threat Behav 22(4):479–493. https://doi.org/10.1111/j.1943-278X.1992.tb01040.x
Chatterjee I (2018) Mean deviation based identification of activated voxels from time-series fMRI data of schizophrenia patients. F1000Res 7:1615. https://doi.org/10.12688/f1000research.16405.2
Chatterjee I, Mittal K (2019) A concise study of schizophrenia and resting-state fMRI data analysis. Qeios 414:2. https://doi.org/10.32388/599711.2
Chatterjee I, Kumar V, Sharma S, Dhingra D, Rana B, Agarwal M, Kumar N (2019) Identification of brain regions associated with working memory deficit in schizophrenia. F1000Res 8:124. https://doi.org/10.12688/f1000research.17731.1
Chatterjee I, Kumar V, Rana B, Agarwal M, Kumar N (2020) Identification of changes in grey matter volume using an evolutionary approach: an MRI study of schizophrenia. Multimedia Syst 26:383–396. https://doi.org/10.1007/s00530-020-00649-6
Chua SE, McKenna PJ (1995) Schizophrenia—A brain disease? A critical review of structural and functional cerebral abnormality in the disorder. Br J Psychiatry 166:563–582. https://doi.org/10.1192/bjp.166.5.563
Delaney SB, Fallon A, Alaedini R, Yolken A, Indart T, Feng Y, Wang D, Javitt (2019) Inflammatory biomarkers in psychosis and clinical high risk populations. Schizophr Res 206:440–443. https://doi.org/10.1016/j.schres.2018.10.017
Dickinson D, Ramsey ME, Gold JM (2007) Overlooking the obvious: a meta-analytic comparison of digit symbol coding tasks and other cognitive measures in schizophrenia. Arch Gen Psychiatry 64(5):532–542. https://doi.org/10.1001/archpsyc.64.5.532
Diwadkar VA, Pruitt P, Goradia D, Murphy E, Bakshi N, Keshavan MS, Rajan U, Reid A, Zajac-Benitez C (2011) Fronto-parietal hypoactivation during working memory independent of structural abnormalities: conjoint fMRI and sMRI analyses in adolescent offspring of schizophrenia patients. Neuroimage 58(1):234–241. https://doi.org/10.1016/j.neuroimage.2011.06.033
Fellerhoff B, Laumbacher B, Mueller N, Gu S, Wank R (2007) Associations between Chlamydophila infections schizophrenia and risk of HLA-A10. Mol Psychiatry 12:264–272. https://doi.org/10.1038/sj.mp.4001925
First MB, Reed GM, Hyman SE, Saxena S (2015) The development of the ICD-11 clinical descriptions and diagnostic guidelines for mental and behavioural disorders. World Psychiatry 14:82–90
Fitz Gerald GA (2016) Measure for measure: biomarker standards and transparency. Sci Transl Med 8(343):343fs10. https://doi.org/10.1126/scitranslmed.aaf8590
Focking M, Dicker P, Lopez LM, Cannon M, Schafer MR, McGorry PD, Smesny S, Cotter DR, Amminger GP (2016) Differential expression of the inflammation marker IL12p40 in the at-risk mental state for psychosis: a predictor of transition to psychotic disorder? BMC Psychiatry 16(1):326
Fusar-Poli P, Rutigliano G, Stahl D, Davies C, Bonoldi I, Reilly T, McGuire P (2017) Development and validation of a clinically based risk calculator for the transdiagnostic prediction of psychosis. JAMA Psychiat 74:493–500. https://doi.org/10.1001/jamapsychiatry.2017.0284
Garety PA, Freeman D, Jolley S, Bebbington PE, Kuipers E, Dunn G, Fowler DG, Dudley R (2005) Reasoning, emotions, and delusional conviction in psychosis. J Abnorm Psychol 114(3):373–384. https://doi.org/10.1037/0021-843X.114.3.373
Goldsmith DR, Rapaport MH, Miller BJ (2016) A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression. Mol Psychiatry 21:1696–1709. https://doi.org/10.1038/mp.2016.3
Guyton AC, Hall JE (2006) Textbook of medical physiology, 11th edn. Elsevier Saunders, Philadelphia
Heilä H, Heikkinen ME, Isometsä ET, Henriksson MM, Marttunen MJ, Lönnqvist JK (1999) Life events and completed suicide in schizophrenia. A comparison of suicide victims with and without schizophrenia. Schizophr Bull 25(3):519–531. https://doi.org/10.1093/oxfordjournals.schbul.a033398
Heinrichs RW, Zakzanis KK (1998) Neurocognitive deficit in schizophrenia: a quantitative review of the evidence. Neuropsychology 12(3):426–445. https://doi.org/10.1037/0894-4105.12.3.426
Hidese S, Ota M, Matsuo J, Ishida I, Hiraishi M, Teraishi T, Hattori K, Kunugi H (2017) Association between the scores of the Japanese version of the brief assessment of cognition in schizophrenia and whole-brain structure in patients with chronic schizophrenia: a voxel-based morphometry and diffusion tensor imaging study. Psychiatry Clin Neurosci 71:826–835. https://doi.org/10.1111/pcn.12560
Insel T, Cuthbert B (2010) Research Domain Criteria (RDoC): toward a new classification framework for research on mental disorders. Am J Psychiatry 167(7):748–751. https://doi.org/10.1176/appi.ajp.2010.09091379
Jackson HJ, McGorry PD, McKenzie D (1994) The reliability of DSM-III prodromal symptoms in first-episode psychotic patients. Acta Psychiatr Scand 90(5):375–378. https://doi.org/10.3109/00048679609062654
Jensen JE, Drost DJ, Menon RS, Williamson PC (2002) In vivo brain 31 P-MRS: measuring the phospholipid resonances at 4 tesla from small voxels. NMR Biomed 15:338–347. https://doi.org/10.1002/nbm.776
Kaneda Y, Keefe RSE (2015) An abbreviated version of the brief assessment of cognition in schizophrenia (BACS). Eur J Psychiatry 29(2):131–134. https://doi.org/10.4321/S0213-61632015000200004
Kasai K, Shenton ME, Salisbury DF et al (2003) Progressive decrease of left superior temporal gyrus gray matter volume in patients with first episode schizophrenia. Am J Psychiatry 160:156–164. https://doi.org/10.1176/appi.ajp.160.1.156
Kebabian JW, Calne DB (1979) Multiple receptors for dopamine. Nature 277:93–96. https://doi.org/10.1038/277093a0
Keefea R, Goldbergb TE, Harveyc PD, Goldd JM, Poea MP, Coughenour L (2004) The brief assessment of cognition in schizophrenia: reliability, sensitivity, and comparison with a standard neurocognitive battery. Schizophr Res 68:283–297. https://doi.org/10.1016/j.schres.2003.09.011
Kirkpatrick B, Miller BJ (2013) Inflammation and schizophrenia. Schizophr Bull 39:1174–1179. https://doi.org/10.1093/schbul/sbt141
Komoroski RA, Pearce JM, Mrak RE (2008) 31 P NMR spectroscopy of phospholipid metabolites in postmortem schizophrenic brain. Magn Reson Med 59:469–474. https://doi.org/10.1002/mrm.21516
Kontaxakis V, Havaki-kontaxaki B, Margariti M, Stamouli S, Kollias C, Christodoulou G (2004) Suicidal ideation in inpatients with acute schizophrenia. Can J Psychiatry 49(7):5–8. https://doi.org/10.1177/070674370404900709
Laney D, Philip N, Miller BJ (2015) Recurrent urinary tract infections in acute psychosis. Schizophr Res 164(2015):275–276. https://doi.org/10.1016/j.schres.2015.02.018
Lee T, Seeman P, Tourtellotte WW, Farley IJ, Hornykeiwicz. (1978) Binding of 3H-apomorphine in schizophrenic brains. Nature 274:897–900. https://doi.org/10.1038/274897a0
Lieberman J, Chakos M, Wu H et al (2001) Longitudinal study of brain morphology in first episodes of schizophrenia. Biol Psychiatry 49:487–499. https://doi.org/10.1016/s0006-3223(01)01067-8
Maj M (1998) Critique of the DSM–IV operational diagnostic criteria for schizophrenia. Br J Psychiatry 172(6):458–460. https://doi.org/10.1192/bjp.172.6.458
Malla AK, Mittal C, Lee M, Scholten DJ, Assis L, Norman MG (2002) Computed tomography of the brain morphology of patients with first-episode schizophrenic psychosis. J Psychiatry Neurosci 7(5):350–358
Mazza MG, Lucchi S, Rossetti A, Clerici M (2019) Neutrophil-lymphocyte ratio, monocyte-lymphocyte ratio and platelet-lymphocyte ratio in non-affective psychosis: a meta-analysis and systematic review. World J Biol Psychiatry 21:326. https://doi.org/10.1080/15622975.2019.1583371
McGuireP OD, Howes J, Stone P, Fusar-Poli. (2008) Functional neuroimaging in schizophrenia: diagnosis and drug discovery. Trends Pharmacol Sci 29(2):91–98. https://doi.org/10.1016/j.tips.2007.11.005
Miller BJ, Goldsmith DR (2019) Inflammatory biomarkers in schizophrenia, implications for heterogeneity and neurobiology. Biomark Neuropsychiatry 1(2019):1–11. https://doi.org/10.1016/j.bionps.2019.100006
Miller BJ, Graham KL, Bodenheimer CM, Culpepper NH, Waller JL, Buckley PF (2013) A prevalence study of urinary tract infections in acute relapse of schizophrenia. J Clin Psychiatry 73:271–277. https://doi.org/10.4088/JCP.12m08050
Mintz AR, Dobson KS, Romney DM (2003) Meta-analysis, the relationships between insight and symptom. Schizophr Res 61:75–88. https://doi.org/10.1016/s0920-9964(02)00316-x
Monroe JM, Buckley PF, Miller BJ (2015) Meta-analysis of anti-toxoplasma gondii IgM antibodies in acute psychosis. Schizophr Bull 41(4):989–998. https://doi.org/10.1093/schbul/sbu159
Nitta MT, Kishimoto N, Müller M, Weiser M, Davidson JM, Kane (2013) Adjunctive use of nonsteroidal anti-inflammatory drugs for schizophrenia: a meta-analytic investigation of randomized controlled trials. Schizophr Bull 39:1230–1241. https://doi.org/10.1093/schbul/sbt070
Novak J, Wilson M, Mac Pherson L, Arvanitis TN, Davies NP, Peet AC (2014) Clinical protocols for 31 P MRS of the brain and their use in evaluating optic pathway gliomas in children. Eur J Radiol 83(2014):e106–e112. https://doi.org/10.1016/j.ejrad.2013.11.009
Owen F, Cross AJ, Crow TJ, Longden A, Poulter M, Riley GJ (1978) Increased dopamine-receptor sensitivity in schizophrenia. Lancet 2:223–225. https://doi.org/10.1016/S0140-6736(78)91740-3
Park S, Miller BJ (2019) Meta-analysis of cytokine and C-reactive protein levels in high-risk psychosis. Schizophr Res 226:5–12. https://doi.org/10.1016/j.schres.2019.03.012
Park MH, Kwon YJ, Jeong HY, Lee HY, Hwangbo Y, Yoon HJ (2012) Association between intracellular infectious agents and schizophrenia. Clin Psychopharmacol Neurosci 10(2):117–123. https://doi.org/10.9758/cpn.2012.10.2.117
Pettegrew JW, Keshavan MS, Panchalingam K, Strychor S, Kaplan DB, Tretta MG, Allen M (1991) Alterations in brain high-energy phosphate and membrane phospholipid metabolism in first-episode, drug-naïve schizophrenics. A pilot study of the dorsal prefrontal cortex by in vivo phosphorus-31 nuclear magnetic resonance spectroscopy. Arch Gen Psychiatry 48:563–568. https://doi.org/10.1001/archpsyc.1991.01810300075011
Redfors PC, Hofgren I, Eriksson L, Holmegaard H, Samuelsson, Jood K (2014) The Barrow neurological institute screen for higher cerebral functions in cognitive screening after stroke. J Stroke Cerebrovasc Dis 23(2):349–355. https://doi.org/10.1016/j.jstrokecerebrovasdis.2013.04.026
Reichenberg A, Harvey PD (2007) Neuropsychological impairments in schizophrenia: integration of performance-based and brain imaging findings. Psychol Bull 133(5):833–858. https://doi.org/10.1037/0033-2909.133.5.833
Saha S, Chant D, McGrath J (2007) A systematic review of mortality in schizophrenia: is the differential mortality gap worsening over time? Arch Gen Psychiatry 64:1123–1131. https://doi.org/10.1001/archpsyc.64.10.1123
Sangadah K, Kartawidjaja J (2020) No 主観的健康感を中心とした在宅高齢者における健康関連指標に関する共分散構造分析. Orphanet J Rare Dis 21(1):1–9
Sawa A, Snyder SH (2002) Schizophrenia: diverse approaches to a complex disease. Science 296:692. https://doi.org/10.1126/science.1070532
Schaefer J, Giangrande E, Daniel R, Dickinson WD (2013) The global cognitive impairment in schizophrenia: consistent over decades and around the world. Schizophr Res 150:42. https://doi.org/10.1016/j.schres.2013.07.009
Shepherd AM, Laurens KR, Matheson SL, Carr VJ, Green MJ (2012) Systematic meta-review and quality assessment of the structural brain alterations in schizophrenia. Neurosci Biobehav Rev 36(4):1342–1356. https://doi.org/10.1016/j.neubiorev.2011.12.015
Smith GN, Flynn SW, Kopala LC et al (1997) A comprehensive method of assessing routine CT scans in schizophrenia. Acta Psychiatr Scand 96:395–401. https://doi.org/10.1111/j.1600-0447.1997.tb09935.x
Sommer IE, Westrhenen R, Begemann MJ, de Witte LD, Leucht S, Kahn RS (2014) Efficacy of anti-inflammatory agents to improve symptoms in patients with schizophrenia: an update. Schizophr Bull 40(2014):181–191. https://doi.org/10.1093/schbul/sbt139
Szeszko PR, Bilder RM, Lencz T et al (2000) Reduced anterior cingulate gyrus volume correlates with executive dysfunction in men with first episode schizophrenia. Schizophr Res 43:97–108. https://doi.org/10.1016/s0920-9964(99)00155-3
Tandon R, Nasrallah HA, Keshavan MS (2009) Schizophrenia, “just the facts” 4. Clinical features and conceptualization. Schizophr Res 110:1–23. https://doi.org/10.1016/j.schres.2009.03.005
Texada JC, Singh SP (2010) Magnetic resonance imaging. In: Canon CL (ed) Radiology specialty board review, 1st edn. McGraw Hill, New York, pp 149–159
Tomasik JE, Schwarz PC, Guest S, Bahn. (2012) Blood test for schizophrenia. Eur Arch Psychiatry Clin Neurosci 262(2):79–83. https://doi.org/10.1007/s00406-012-0354-3
Torrey EF, Bartko JJ, Lun ZR, Yolken RH (2007) Antibodies to toxoplasma gondii in patients with schizophrenia: a meta-analysis. Schizophr Bull 33(2007):729–736. https://doi.org/10.1093/schbul/sbl050
Varshney AC, Prakash N, Mittal P, Singh (2016) A multimodel approach for schizophrenia diagnosis using fMRI and sMRI dataset. In: The International symposium on intelligent systems technologies and applications. Springer, Berlin, pp 869–877. https://doi.org/10.1007/978-3-319-47952-1_69
Walter G, Robertson M, Rey JM, Soh N, Malhi GS (2010) Electroconvulsive therapy in young people and the pioneering spirit of lauretta bender. Acta Neuropsychiatr 22(5):253–254. https://doi.org/10.1111/j.16015215.2010.00487.x
Weinberger DR, Levitt P (2011) Neurodevelopmental origins of schizophrenia. In: Schizophrenia. Wiley‐Blackwell, Oxford, pp 393–412. https://doi.org/10.1002/wps.20474
Yildirim A, Tureli D (2015) Schizophrenia: a review of neuroimaging techniques and findings. East J Med 20:1–6
Yung AR, McGorry PD, McFarlane CA, Jackson HJ, Patton GC, Rakkar A (1996) Monitoring and care of young people at incipient risk of psychosis. Schizophr Bull 22(2):283–303. https://doi.org/10.1093/schbul/22.2.283
Zhang JW, Luo P, Huang L, Peng Q, Huang. (2018) Maternal C-reactive protein and cytokine levels during pregnancy and the risk of selected neuropsychiatric disorders in offspring: a systematic review and meta-analysis. J Psychiatr Res 105:86–94. https://doi.org/10.1016/j.jpsychires.2018.09.002
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Choudhari, M.R., Chatterjee, I. (2023). A Diagnostic Perspective of Schizophrenia: From Past to Present. In: Chatterjee, I. (eds) Cognizance of Schizophrenia:: A Profound Insight into the Psyche. Springer, Singapore. https://doi.org/10.1007/978-981-19-7022-1_4
Download citation
DOI: https://doi.org/10.1007/978-981-19-7022-1_4
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-19-7021-4
Online ISBN: 978-981-19-7022-1
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)